{
    "2018-04-19": [
        [
            {
                "time": "2018-04-19",
                "original_text": "今日资金抢入六只强势股一览（2018年4月19日）",
                "features": {
                    "keywords": [
                        "资金抢入",
                        "强势股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-19",
                "original_text": "机构加速布局“入摩”行情 投资者可布局绩优成长标的",
                "features": {
                    "keywords": [
                        "机构布局",
                        "入摩",
                        "绩优成长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-19",
                "original_text": "北上资金净买入茅台美的 单日净买入额均创次新高",
                "features": {
                    "keywords": [
                        "北上资金",
                        "茅台",
                        "美的",
                        "净买入"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-19",
                "original_text": "恒瑞医药2017年报点评:以研发创新驱动强者恒强",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "年报",
                        "研发创新"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-19",
                "original_text": "[买入评级]新宙邦(300037)季报点评：行业竞争加速 静待量价齐升",
                "features": {
                    "keywords": [
                        "新宙邦",
                        "季报",
                        "量价齐升"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "化工"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-19",
                "original_text": "[优于大市评级]聚焦-产品竞争力系列：恒瑞医药：创新药龙头 研发体系和商业化能力保证未来增长",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "创新药",
                        "研发体系",
                        "商业化能力"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-19",
                "original_text": "[优异评级]医药生物行业研究简报：一致性评价再添新品 相关政策红利逐步释放",
                "features": {
                    "keywords": [
                        "医药生物",
                        "一致性评价",
                        "政策红利"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}